BELOTTI DANIELA
Pubblicazioni
Lussana, F., Magnani, C., Galimberti, S., Gritti, G., Gaipa, G., Belotti, D., et al. (2025). Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation. BLOOD CANCER JOURNAL, 15(1) [10.1038/s41408-025-01260-6]. Dettaglio
Zanier, E., Pischiutta, F., Rulli, E., Vargiolu, A., Elli, F., Gritti, P., et al. (2023). MesenchymAl stromal cells for Traumatic bRain Injury (MATRIx): a study protocol for a multicenter, double-blind, randomised, placebo-controlled phase II trial. INTENSIVE CARE MEDICINE EXPERIMENTAL, 11(1) [10.1186/s40635-023-00535-1]. Dettaglio
Genchi, A., Brambilla, E., Sangalli, F., Radaelli, M., Bacigaluppi, M., Furlan, R., et al. (2023). Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study. NATURE MEDICINE, 29, 75-85 [10.1038/s41591-022-02097-3]. Dettaglio
Capelli, C., Frigerio, S., Lisini, D., Nava, S., Gaipa, G., Belotti, D., et al. (2022). A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies. CYTOTHERAPY, 24(5), 544-556 [10.1016/j.jcyt.2021.12.004]. Dettaglio
Magnani, C., Gaipa, G., Lussana, F., Belotti, D., Gritti, G., Napolitano, S., et al. (2020). Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities. THE JOURNAL OF CLINICAL INVESTIGATION, 130(11), 6021-6033 [10.1172/JCI138473]. Dettaglio